Kilitch Drugs (India) Limited

Web: kilitch.com NSE: KILITCH BSE: 524500 SECTOR: Healthcare - Pharmaceuticals & Biotechnology

202 3(-2%)

Volume

3L as on 23, Jun

Open

323

High

327

Low

320

206

VWAP

194

52 Week High

250

52 Week Low

117

Viand Research Rating

Quality Score

68/100

Growth Score

87/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

707

No. of Shares

3.5

P/E

22.76

P/B

2.25

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

9.89

ROCE

Profit Growth

Listing Date

29-Sep-10

Promoter Holding

63.77%

FII Holding

DII Holding

Price Chart

Price Performance

1 Week3%

1 Month5%

3 Months39%

6 Months39%

1 Year39%

YTD39%

Moving Average

5 Day SMA186

10 Day SMA186

20 Day SMA182

30 Day SMA178

50 Day SMA165

61 Day SMA163

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	200	191	197	202
Resistance 2	197	191	194	198
Resistance 1	193	190	193	196
Pivot Point	190	190	190	191
Support 1	187	189	188	189
Support 2	184	188	186	185
Support 3	180	188	184	182

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,68,075	1951	0%	4%	19%	16%	37	57.7	0.07	11509
2	DIVISLAB	1,93,367	7284	2%	9%	22%	11%	69	57.7	0	2568
3	TORNTPHARM	1,71,221	5059	0%	13%	25%	42%	72	57.7	1.79	2138
4	APOLLOHOSP	1,27,077	8838	0%	6%	31%	21%	58	57.7	0.9	2003
5	CIPLA	1,13,284	1402	2%	0%	3%	4%	22	57.7	0.02	3862
6	ZYDUSLIFE	1,11,092	1114	3%	4%	27%	17%	20	57.7	0.46	5124
7	LUPIN	1,09,480	2394	3%	3%	11%	25%	23	57.7	0.29	5355
8	MAXHEALTH	1,05,425	1083	2%	1%	8%	14%	0	57.7	0.32	1442
9	MANKIND	1,05,070	2544	0%	0%	18%	3%	49	57.7	0.39	1938
10	DRREDDY	97,179	1165	4%	8%	3%	5%	20	57.7	0.2	4158
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 63.77%	(0.01) 63.77%	(-5.51) 63.77%	(0.01) 69.23%	(0.01) 69.23%	(0.01) 69.23%	(0.01) 69.23%	(0.01) 69.23%	(0.01) 69.23%	(0.01) 69.23%	(1.01) 69.23%	(0.01) 68.24%	(0.01) 68.24%	(0.01) 68.24%	(0.01) 68.24%	(0.01) 68.25%	(0.01) 68.25%	(-0.11) 68.25%	(0.01) 68.33%
FIIs	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.03%	(0.01) 0.00%
Public	36.22%	36.23%	36.22%	30.77%	30.77%	30.76%	30.77%	30.77%	30.77%	30.76%	30.78%	31.76%	31.75%	31.75%	31.75%	31.75%	31.75%	31.73%	31.67%
No. of Shareholders	11,785	12,043	10,929	10,379	9,749	10,139	9,920	9,620	9,525	9,062	9,002	9,573	9,522	9,435	9,380	9,209	9,133	9,129	8,740

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	90	54	49	43	61	56	47	33	45	32	41	37	45	29.97	30.7	33.45	37	34.43	23.57	19.62
Sales Growth % (YoY)	46.3%	-4.2%	3%	29%	36.6%	76.7%	15.2%	-8.5%	-1.4%	6.1%	34.2%	9.3%	24.2%	-13%	30.2%	70.5%	83.7%	69%	30.4%	92.5%
Sales Growth % (QoQ)	66.7%	10.2%	14%	-29.5%	8.9%	19.1%	42.4%	-26.7%	40.6%	-22%	10.8%	-17.8%	50.2%	-2.4%	-8.2%	-9.6%	7.5%	46.1%	20.1%	-
Expenses	67	48	44	40	47	47	41	32	38	30	33	30	39	25.99	26.75	30.03	32	33.66	19.92	18.71
Operating Profit	22	6	5	3	15	9	6	2	7	2	9	6	6	3.98	3.95	3.42	5	0.77	3.65	0.91
OPM %	25	11	10	8	24	16	13	5	16	7	21	17	14	13.28	12.87	10.22	14	2.24	15.49	4.64
Other Income	0	2	7	3	2	2	5	3	0	3	0	1	1	0.69	0.24	0.97	0	1.31	0.17	1.05
Interest	1	1	1	2	2	1	0	2	1	2	2	2	1	1.29	1.75	0.67	1	0.24	0.12	0.13
Depreciation	1	1	1	1	1	1	1	1	1	1	1	1	1	0.93	0.89	0.82	1	0.2	0.7	0.44
Profit before tax	20	6	9	3	14	8	10	2	5	3	7	5	5	2.45	1.55	2.9	4	1.64	3	1.39
Tax %	26	23	14	34	26	32	17	93	31	38	25	33	43	30.61	-25.16	40	36	62.8	14	47.48
Net Profit	15	4	8	2	10	6	9	0	4	2	5	3	3	1.71	1.94	1.74	2	0.61	2.58	0.72
Net Profit Growth % (QoQ)	275%	-50%	300%	-80%	66.7%	-33.3%	100%	-100%	100%	-60%	66.7%	-	75.4%	-11.9%	11.5%	-13%	227.9%	-76.4%	258.3%	-
Net Profit Growth % (YoY)	50%	-33.3%	-11.1%	100%	150%	200%	80%	-100%	33.3%	17%	157.7%	72.4%	50%	180.3%	-24.8%	141.7%	-	-	-	-
TTM Net Profit	29	24	26	27	25	19	15	11	14	13	12.71	9.65	8.39	7.39	6.29	6.93	5.91	3.91	3.3	0
EPS in Rs	4.15	1.27	2.34	0.87	2.97	1.7	2.46	0.38	1.03	0.83	1.35	0.99	1.05	1.4	1.44	1.24	1.72	0.72	1.39	0.76

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2012	Mar 2011
Sales	235	198	154	140	114	68	53	82	51	27	21	19	108	146
Sales Growth %	18.7%	28.5%	10.6%	22.2%	67%	28.3%	-35.3%	61.7%	87%	30.4%	10.4%	-	-26.2%	2.6%
Expenses	199	167	130	122	104	63	53	75	45	28	25	21	95	124
Operating Profit	37	32	24	18	10	5	0	7	6	-1	-4	-2	13	22
OPM %	16	16	16	13	9	8	1	9	11	-2	-19	-9	12	15
Other Income	11	11	4	3	3	3	4	4	3	1	2	3	92	0
Interest	6	5	6	5	1	1	1	1	0	0	0	0	3	4
Depreciation	4	3	3	4	2	2	2	2	2	10	10	2	5	6
Profit before tax	39	34	19	12	10	5	2	9	6	-9	-12	-1	97	13
Tax %	24	28	30	31	35	27	48	55	16	-5	-4	-70	22	20
Net Profit	30	25	14	8	6	4	1	4	5	-9	-11	0	76	10
Net Profit Growth %	20%	78.6%	75%	33.3%	50%	300%	-75%	-20%	155.6%	18.2%	-	-100%	660%	-
EPS in Rs	8.63	7.63	4.17	3.08	2.17	1.09	0.25	1.15	1.72	-3.09	-3.89	-0.1	52.99	7.93
Dividend Payout %	0	0	0	0	0	0	0	20	13	0	0	0	52	13

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2012	Mar 2011
Cash from Operating Activity	24	18	-2	3	6	46	4	0	1	1	17	-8	-29	22
Cash from Investing Activity	-100	-40	-8	8	-15	-38	-10	-14	-4	-2	-20	-31	41	-24
Cash from Financing Activity	82	13	9	-1	7	2	1	17	6	0	0	0	-9	7
Net Cash Flow	6	-9	-1	10	-2	10	-5	3	2	0	-2	-39	2	6

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2012	Mar 2011
Equity Capital	35	17	16	16	16	16	16	15	15	15	14	13	13	13	13	13
Reserves	245	248	186	173	160	136	124	112	103	106	98	88	95	107	101	71
Borrowings	89	84	49	32	32	22	20	15	13	9	1	1	0	0	9	16
Other Liabilities	89	49	61	38	32	46	50	61	12	13	15	11	8	7	54	53
Total Liabilities	458	399	313	259	240	220	210	203	143	144	128	113	117	127	177	153
Fixed Assets	67	64	64	63	62	64	65	30	32	32	33	33	42	9	9	42
CWIP	140	98	47	22	6	4	3	65	30	20	3	1	0	0	0	43
Investments	75	77	72	76	72	62	71	60	52	53	56	53	49	72	138	0
Other Assets	176	160	129	99	100	90	71	47	30	38	35	26	25	46	30	68
Total Assets	458	399	313	259	240	220	210	203	143	144	128	113	117	127	177	153

Delivery

#	Date	151 38% 208	Value (Cr)	Q/T 60	Del 40	Del 4
1	2-Jul	197	3	39	59	2
2	1-Jul	206	5	42	42	2
3	30-Jun	195	4	44	39	1
4	29-Jun	186	3	64	39	1
5	25-Jun	185	1	43	48	1
6	24-Jun	191	2	40	49	1
7	23-Jun	192	7	62	37	2
8	22-Jun	190	3	47	47	1
9	19-Jun	186	2	69	50	1
10	18-Jun	183	2	55	50	1
11	17-Jun	182	4	33	33	1
12	16-Jun	186	1	37	38	0
13	15-Jun	184	2	50	54	1
14	12-Jun	189	2	51	47	1
15	11-Jun	182	2	46	33	1
16	10-Jun	183	7	67	26	2
17	9-Jun	187	6	86	25	2
18	8-Jun	167	1	36	48	1
19	5-Jun	174	1	44	53	0
20	4-Jun	178	1	32	37	0
21	3-Jun	173	1	44	47	1
22	2-Jun	179	3	50	43	1
23	1-Jun	181	1	49	37	1
24	29-May	182	3	43	47	1
25	27-May	182	1	44	47	1
26	26-May	181	3	64	21	1
27	25-May	185	3	56	50	1
28	22-May	182	2	40	29	0
29	21-May	183	3	59	37	1
30	20-May	184	6	54	38	2
31	19-May	174	3	52	37	1
32	18-May	169	31	89	26	8
33	15-May	154	0	34	51	0
34	14-May	155	2	67	33	1

Daily Market Cap

Date	Total Market Cap	Change	Chg %
02-Jul	707c	10c	1.35
01-Jul	717c	37c	5.48
30-Jun	680c	35c	5.45
29-Jun	644c	2c	0.38
26-Jun	647c	9c	1.39
25-Jun	656c	12c	1.77
24-Jun	668c	5c	0.80
23-Jun	673c	9c	1.40
22-Jun	664c	7c	1.01
19-Jun	657c	23c	3.58
17-Jun	635c	18c	2.68
16-Jun	652c	12c	1.91
15-Jun	640c	19c	2.81
12-Jun	658c	9c	1.32
11-Jun	650c	73L	0.11
10-Jun	651c	0	0

Stock Checklist

Price is above from 52 week high low average: 28%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

No mutual fund holding data available.

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements

Corporate Announcements

NseIndia | Trendlyne | Screener | TradingView